Vertex Pharmaceuticals (VRTX) held an investor conference Wednesday, where company management stated that refills for its cystic fibrosis drug Orkambi have slowed down in July and August.
from RTT - Before the Bell http://ift.tt/2d0iexk
via IFTTT
No comments:
Post a Comment